Apyx Medical Corp (NASDAQ:APYX) is set to release its Q4 2024 earnings on Jan 30, 2025. The consensus estimate for Q4 2024 ...

In this article, we are going to take a look at where Apyx Medical Corporation (NASDAQ:APYX) stands against the other cosmetic surgery and aesthetics stocks. In the face of economic uncertainty ...

Total revenue expected to be in a range of approximately $14.1 to $14.3 million, representing a decrease of 4% to 3% year-over-year. Total revenue expected to be in a range of approximately $48.0 ...

Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Apyx Medical (APYX – Research Report) today. The company’s shares closed yesterday ...

Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies ...

As per the closing statements of the filing, a signed confirmation by Matthew Hill, who serves as Apyx Medical Corporation’s Chief Financial Officer, Secretary, and Treasurer, confirms the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Advanced Energy revenue increase by more than 25% quarter-over-quarter in Q4 2024CLEARWATER, Fla, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the ...

In a report released today, Matt Hewitt from Craig-Hallum reiterated a Buy rating on Apyx Medical (APYX – Research Report). The company’s ...